European API footprint EUROAPI operates five European manufacturing sites across France, Italy, Germany, and Hungary, serving customers in over 80 countries. This regional concentration supports reliable supply chains and potential for co-located sourcing, fast ramp-ups, and regional partnerships for customers seeking European-produced APIs.

CDMO and portfolio breadth With a diverse portfolio of approximately 200 API products and ongoing CDMO activities, EUROAPI offers development to manufacturing capabilities that can support customers from early development to commercial supply, enabling collaborations on new drug programs and scale-up partnerships.

Public health emphasis EUROAPI’s mission to improve access to essential therapies highlights opportunities to partner on affordable, high-quality APIs for essential medicines, potentially attracting bids from health-focused programs, governments, and NGOs seeking reliable European suppliers.

Strategic transformation The focus on the FOCUS-27 transformation plan and ongoing evaluation of strategic options for assets such as the Brindisi site suggest opportunities to align sales with capability expansions, site optimization, and potential commitments for long-term supply agreements tied to asset redevelopment.

Sustainability and reliability EUROAPI emphasizes high-quality, sustainable API solutions with a track record of reliability. This positions it well for customers prioritizing compliant, traceable supply chains, long-term partnerships, and supplier risk mitigation in regulated markets.